Ahmed Hussein, MD
Interventional Cardiology · Belleville, ILNPI 1104294685
Payments from drug & device makers
What this record shows
This record is dominated by grants: $25,000 of the $31,381 with a category attached, or 79.7%. Boston Scientific accounts for 83.8% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $30,138 and has fallen 97.7% since, to $695 in 2025.
Across 106 payments — averaging $296.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$26K
- Edwards Lifesciences$2K
- Abbott$1K
- Abiomed$1K
- Pfizer$91
- Medtronic$67
- plus $255 from 9 others
What the payments were for
- Grants$25,00080%
- Travel & lodging$3,27810%
- Food & beverage$3,10210%
- Education$10%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 16 | $26,307 |
| Edwards Lifesciences | 46 | $2,356 |
| Abbott | 14 | $1,246 |
| Abiomed | 10 | $1,058 |
| Pfizer | 4 | $91 |
| Medtronic | 3 | $67 |
| Amgen | 2 | $39 |
| Bayer | 2 | $38 |
| AstraZeneca | 2 | $36 |
| Chiesi USA, Inc. | 2 | $36 |
| E.r. Squibb & Sons, L.L.C. | 1 | $27 |
| Bridgebio Pharma, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $21 |
| Novartis | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PASCAL$1,003
- MitraClip$969
- VersaCross Access Solution$888
- Impella$804
- LUX-Dx Insertable Cardiac Monitor$150
- SAPIEN 3 Ultra RESILIA$133
How this compares
$31,381 in reported general payments places this provider in the 80th percentile of 303 interventional cardiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Belleville
- Andrei PopElk Grove Village$900K
- Atman ShahChicago$788K
- Ravi RamanaPalos Park$458K
- Mahesh RajuDowners Grove$281K
- Mark RicciardiEvanston$253K
- Neal SawlaniPark Ridge$246K
- Tony de MartiniSpringfield$208K
- Bouyella ReddyMoline$172K
- David StewartChicago$169K
- Jaafer GolzarOak Lawn$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.